Overview

An Observational Study to Predict the Response of Erythropoietin Treatment in Participants With Cancer Related Anemia Receiving Chemotherapy

Status:
Terminated

Trial end date:
2012-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this observational study is to evaluate the predictors of response to erythropoietin (hormone secreted by kidney that helps in formation of red blood cells in bone marrow) treatment in participants with cancer (abnormal tissue that grows and spreads in the body until it kills) related anemia (decreased number of red blood cells), receiving chemotherapy (treatment of cancer using drugs).

Details

Lead Sponsor:

Janssen-Cilag Ltd.,Thailand

Collaborator:

Mahidol University

Treatments:

Epoetin Alfa